PH
Pharming
PHARM.AS·AMSLeiden NLFounded 1988700 employees
Small CapbiotechPublicRare Disease
Platform: C1-INH
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (PHARM.AS)
Loading PHARM.AS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| PHA-4842 | PHA-4842 | Approved | 1 | BTK | MelanomaHNSCC | ||
| Pexazanubrutinib | PHA-9801 | Phase 1/2 | 2 | BTK | PNHPancreatic Ca |
SEC Filings & Financial Documents
SEC filings are not available for AMS-listed companies.
Pharming trades on AMS (NL). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)